DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Hanania NA, Noonan M, Corren J. , et al.
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.
Thorax 2015;
70 (08) 748-756
We do not assume any responsibility for the contents of the web pages of other providers.